We spoke with International Journal of Biometeorology editor-in-chief Scott Sheridan about the case: Read the rest of this entry »
The retraction notice indicates that the patients never consented, there was no ethical review, and the university supposedly overseeing the study had no knowledge of it:
The European Science Foundation (ESF) has threatened legal action against a scientist for calling an evaluation process supported by the agency “flawed” in a commentary piece in Nature.
Amayo Moro-Martin, an assistant astronomer at the Space Telescope Science Institute (STScI) and an associate research scientist at The Johns Hopkins University, apparently angered the ESF with the bolded phrase below: Read the rest of this entry »
We’ve written before about how common cell line mix ups are in cancer research; according to a 2012 Wall Street Journal article (paywalled), between a fifth and a third of cancer cell lines tested by suspicious researchers turned out to be misidentified.
Obviously, mistakenly studying the wrong kind of cancer is a waste of precious resources, both time and money. And it’s clear the problem hasn’t gone away. PLoS ONE just retracted a cancer paper originally published in December 2012 for studying two cell lines that had been contaminated by other cell types.